Evidence map›Paper›PMID 33073485›Full record

ArticleHelicobacter2021

A comparative whole genome analysis of Helicobacter pylori from a human dense South Asian setting.

Shamsul Qumar, Trang Hoa Nguyen, Shamsun Nahar, Nishat Sarker, Stephen Baker, Dieter Bulach, Niyaz Ahmed, Motiur Rahman

Open access · hybridAbstract read
In one paragraph

Article in Helicobacter, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Integrative profiling ofMicrobial genomics · 2026
    Article
  2. Helicobacter pylori Infection in Colombia: Phylogeny, Resistome, and Virulome.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2025
    Article
  3. Article
  4. Article
  5. Mutations Related to Antibiotics Resistance inAntibiotics (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. PeerJ · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 7 countries.

Shamsul QumarDepartment of Biotechnology and Bioinformatics, University of Hyderabad, Hyderabad, India.
Trang Hoa NguyenThe Hospital for Tropical Diseases, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Shamsun NaharInternational Center for Diarrhoeal Disease Research Bangladesh, Dhaka, Bangladesh.
Nishat SarkerInternational Center for Diarrhoeal Disease Research Bangladesh, Dhaka, Bangladesh.
Stephen BakerCambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge University, Cambridge, UK.
Dieter BulachThe University of Melbourne and The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Niyaz AhmedDepartment of Biotechnology and Bioinformatics, University of Hyderabad, Hyderabad, India.
Motiur RahmanThe Hospital for Tropical Diseases, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.ORCID https://orcid.org/0000-0002-6702-5355
International Centre for Diarrhoeal Disease Research · BDAngkor Hospital for Children · KHOxford University Clinical Research Unit · VNThe University of Melbourne · AUUniversity of Cambridge · GBUniversity of Hyderabad · IN

Funding

Oxford University Clinical Research Unit, Vietnam
6 · The paper itself

Abstract

Helicobacter pylori, a Gram-negative bacterium, is associated with a wide range of gastric diseases such as gastritis, duodenal ulcer, and gastric cancer. The prevalence of H pylori and risk of disease vary in different parts of the world based on the prevailing bacterial lineage. Here, we present a contextual and comparative genomics analysis of 20 clinical isolates of H pylori from patients in Bangladesh. Despite a uniform host ethnicity (Bengali), isolates were classified as being part of the HpAsia2 (50%) or HpEurope (50%) population. Out of twenty isolates, eighteen isolates were cagA positive, with two HpEurope isolates being cagA negative, three EPIYA motif patterns (AB, AB-C, and ABC-C) were observed among the cagA-positive isolates. Three vacA genotypes were observed with the s1m1i1dic1 genotype observed in 75% of isolates; the s1m2i1d1c2 and s2m2i2d2c2 genotypes were found to be 15% and 10% of isolates, respectively. The non-virulent genotypes s2m2i2d2c2 was only observed in HpEurope population isolates. Genotypic analysis of oipA gene, present in all isolates, revealed five different patterns of the CT repeat; all HpAsia2 isolates were in "ON" while 20% of HpEurope isolates were genotypically "OFF." The three blood group antigen binding adhesins encoded genes (bab genes) examined and we observed that the most common genotype was (babA/babB/-) found in eight isolates, notably six were HpAsia2 isolates. The babA gene was found in all HpAsia2 isolates but present in only half of the HpEurope isolates. In silico antibiotic susceptibility analysis revealed that 40% of the strains were multi-drug resistant. Mutations associated with resistance to metronidazole, fluoroquinolone, and clarithromycin were detected 90%, 45%, and 5%, respectively, in H pylori strain. In conclusion, it is evident that two populations of H pylori with similar antibiotic profiles are predominant in Bangladesh, and it appears that genotypically the HpAisa2 isolates are potentially more virulent than the HpEurope isolates.

Indexed as

GastritisGenome, BacterialHelicobacter InfectionsHelicobacter pyloriAntigens, BacterialBacterial ProteinsBangladeshDrug Resistance, BacterialGenomicsGenotypeHumansAntigens, BacterialBacterial Proteinsgenome sequencingH pyloriouter membrane proteinsphylogenyvirulence

Identifiers

PMID33073485
PMCPMC7816255
OpenAlexW3092849729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.